Physician Assistant, Medical · New Haven, CT
NPI
1558306340
Since 2006
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
20 York Steet, Cb-2041
New Haven, CT, 06510
Phone (203) 688-4748
Medicare paid, 2024
$15K
359 services
Medicare patients, 2024
106
Average age 76
Drug cost, 2024
$3.4M
1,838 prescriptions
Company payments, 2025
$17.3
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Rodonski was code 99214 (office e&m - established), 169 times for 102 patients. In total Anna Rodonski billed 359 services in 8 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 169 | 102 | $74.41 | $13K |
| 93000 Electrocardiogram | Office | 166 | 99 | $8.27 | $1,373 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 11 | 11 | $10.34 | $114 |
By year: 2022 $20K for 366 services; 2023 $16K for 375 services; 2024 $15K for 359 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anna Rodonski prescribed most often to Medicare patients was Camzyos (Mavacamten), with 304 prescriptions and refills. In total Anna Rodonski wrote 1,838 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Camzyos Mavacamten | 304 | 304 | 44 | $2.5M |
| Jardiance Empagliflozin | 162 | 206 | 43 | $113K |
| Atorvastatin Calcium Generic | 131 | 363 | 54 | $1,507 |
| Spironolactone Generic | 128 | 299 | 49 | $1,058 |
| Metoprolol Succinate Generic | 125 | 317 | 52 | $1,788 |
| Torsemide Generic | 95 | 180 | 42 | $1,979 |
| Ezetimibe Generic | 75 | 185 | 25 | $1,311 |
| Rosuvastatin Calcium Generic | 61 | 155 | 22 | $1,002 |
| Furosemide Generic | 52 | 129 | 21 | $292 |
| Losartan Potassium Generic | 52 | 130 | 22 | $446 |
| Eliquis Apixaban | 51 | 91 | 19 | $54K |
| Clopidogrel Clopidogrel Bisulfate | 48 | 124 | 19 | $641 |
| Olmesartan Medoxomil Generic | 48 | 135 | 21 | $994 |
| Carvedilol Generic | 41 | 100 | 13 | $384 |
| Amlodipine Besylate Generic | 38 | 82 | 16 | $193 |
Brand drugs: 646 claims; generic drugs: 1,192 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Rodonski $17.3 ($17.3 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $17.3.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $17.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.